about
Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeuticsAmeliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain InjuryNitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.Nitrones as therapeutics.Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy.Anti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancerSuperoxide dismutase mimics: chemistry, pharmacology, and therapeutic potentialFast reactivity of a cyclic nitrone-calix[4]pyrrole conjugate with superoxide radical anion: theoretical and experimental studiesComparative approaches to facilitate the discovery of prolongevity interventions: effects of tocopherols on lifespan of three invertebrate species.Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 miceCompounds that confer thermal stress resistance and extended lifespan.Puzzles, promises and a cure for ageing.Synthesis of N-arylpyridinium salts bearing a nitrone spin trap as potential mitochondria-targeted antioxidants.Lipophilic beta-cyclodextrin cyclic-nitrone conjugate: synthesis and spin trapping studiesA class of imidazolium salts is anti-oxidative and anti-fibrotic in hepatic stellate cells.Neuroprotective antioxidant STAZN protects against myocardial ischemia/reperfusion injury.(2Z)-2-Anilino-2-[oxido(phen-yl)iminio]-N-(2-pyrid-yl)acetamide methanol 0.425-solvateRate constants of hydroperoxyl radical addition to cyclic nitrones: a DFT study.The novel antioxidant edaravone: from bench to bedside.Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models.RETRACTED ARTICLE: TN-2 Ameliorates Tunicamycin-Induced Mitochondria and Endoplasmic Reticulum Stress-Associated Apoptosis in Rat Dorsal Root Ganglion Neurons.
P2860
Q28818673-AED955ED-7F9A-471C-A248-6E4DC4AA6CA9Q30387426-1C1B6E75-F7A5-4AAD-8390-9EE0E6C9CA9CQ30431810-7A534449-73DD-4DC8-889D-C837F0B73C63Q30484564-5A74C241-8AFB-42F0-AE3E-9FDA4ED950B0Q30828492-19F4BE1D-5573-419A-812A-5EEF238F4B57Q33514735-A03198B8-271A-4033-8713-F479370C0D79Q34110107-012F896F-9720-429D-90CF-08CB7E62D103Q35064581-0A284216-0A84-4F1F-939C-0D90880330E7Q35676510-BC1BE4EC-57C7-4722-9DD7-5EB38059DFE3Q36973998-B54EFFDD-D99A-4821-AE1B-0CDC701F823DQ37015768-EAC1F504-582A-405A-AC35-E144578AF139Q37255737-C13CA1E9-593F-4975-AE07-A1BAA1D37743Q37293674-639DDB69-E5DD-4488-88C1-F4478D68B43CQ37329376-11E6D3CD-7EAD-45E4-B5E0-90BC1175699DQ39814146-678D178C-84A1-4AF6-BFB3-1A672A9E456CQ42118016-FC9381A7-6149-445A-BFEE-B7D84B749E9AQ42404484-2CE929D4-F022-401F-BB9F-0E210E524B2CQ42724110-187F62D4-3F8E-4676-B755-AB58D5367AF0Q46591722-1176333F-5E03-45B6-8FE1-8D91D9732AA1Q48606610-419AD333-3C43-4967-8635-45DA37EB1755Q48789564-2E62E244-20A0-45E0-A9F9-8B020C3D5EA5
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Nitrones as therapeutics in age-related diseases.
@ast
Nitrones as therapeutics in age-related diseases.
@en
type
label
Nitrones as therapeutics in age-related diseases.
@ast
Nitrones as therapeutics in age-related diseases.
@en
prefLabel
Nitrones as therapeutics in age-related diseases.
@ast
Nitrones as therapeutics in age-related diseases.
@en
P2860
P1433
P1476
Nitrones as therapeutics in age-related diseases.
@en
P2093
Robert A Floyd
P2860
P356
10.1111/J.1474-9726.2006.00189.X
P577
2006-02-01T00:00:00Z